X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
WYETH LTD Fact Sheet, WYETH LTD Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD Fact Sheet   (WYLD)

Here is the latest financial fact sheet of WYETH LTD. For more details, see the WYETH LTD quarterly results and WYETH LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.

WYETH LTD Price History

Price Rs 1,334.6
Mkt Cap Rs m 30,322
Vol '000 6.2
P/E X 27.7
P/CF X 22.8
EPS (TTM) Rs 48.1
% ch % -2.3
No. of shares m 22.72
% ch week % 7.5
% ch 1-mth % 18.6
% ch 12-mth % 69.6
52 week H/L Rs 1,409.0/688.3
(As on Dec 9, 2014 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

WYETH LTD Financials

No. of Mths
Year Ending
12
Mar-09
8
Nov-09
16
Mar-11
12
Mar-12
12
Mar-13
5-Yr Chart
Click to enlarge
WYETH LTD EQUITY SHARE DATA
High Rs5097739001,0751,044 
Low Rs348414691794818 
Sales per share (Unadj.) Rs168.4126.0282.2259.0298.6 
Earnings per share (Unadj.) Rs43.926.072.863.757.2 
Diluted earnings per shareRs43.926.072.863.757.2 
Cash flow per share (Unadj.) Rs46.928.976.766.358.4 
Dividends per share (Unadj.) Rs32.5020.0022.0018.0017.00 
Adj. dividends per shareRs32.5020.0022.0018.0017.00 
Dividend yield (eoy) %7.63.42.81.91.8 
Book value per share (Unadj.) Rs119.6122.1169.4212.1249.5 
Adj. book value per shareRs119.6122.1169.4212.1249.5 
Shares outstanding (eoy) m22.7222.7222.7222.7222.72 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x2.54.72.83.63.1 
Avg P/E ratio x9.822.910.914.716.3 
P/CF ratio (eoy) x9.120.510.414.115.9 
Price / Book Value ratio x3.64.94.74.43.7 
Dividend payout %74.177.030.228.329.7 
Avg Mkt Cap Rs m9,73613,48418,07421,23221,157 
No. of employees `0000.80.80.50.50.5 
Total wages/salary Rs m428347513377400 
Avg. sales/employee Rs Th4,638.23,522.312,524.411,339.713,787.4 
Avg. wages/employee Rs Th519.2426.91,001.8727.2813.0 
Avg. net profit/employee Rs Th1,208.2725.73,228.32,788.12,643.3 
WYETH LTD INCOME DATA
Net Sales Rs m3,8272,8646,4135,8856,783 
Other income Rs m215100199340353 
Total revenues Rs m4,0422,9646,6126,2257,136 
Gross profit Rs m1,2867872,2831,7781,617 
Depreciation Rs m6968905927 
Interest Rs m431356 
Profit before tax Rs m1,4298172,3802,0541,938 
Minority Interest Rs m00000 
Prior Period Items Rs m01000 
Extraordinary Inc (Exp) Rs m-50-23-5-5 
Tax Rs m427229704602632 
Profit after tax Rs m9975901,6531,4471,301 
Gross profit margin %33.627.535.630.223.8 
Effective tax rate %29.928.029.629.332.6 
Net profit margin %26.020.625.824.619.2 
WYETH LTD BALANCE SHEET DATA
Current assets Rs m3,8783,6454,1325,6716,984 
Current liabilities Rs m1,5801,2419191,4292,056 
Net working cap to sales %60.084.050.172.172.6 
Current ratio x2.52.94.54.03.4 
Inventory Days Days5376427499 
Debtors Days Days2325193424 
Net fixed assets Rs m389326271257244 
Share capital Rs m227227227227227 
"Free" reserves Rs m2,4902,5483,6214,5925,441 
Net worth Rs m2,7172,7753,8484,8195,668 
Long term debt Rs m2525252525 
Total assets Rs m4,3224,0414,9946,4937,901 
Interest coverage x358.2292.9191.4428.9353.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.71.30.90.9 
Return on assets %23.214.733.322.416.5 
Return on equity %36.721.343.030.022.9 
Return on capital %52.129.361.242.434.0 
Exports to sales %0.20.20.40.10.2 
Imports to sales %21.121.922.728.436.3 
Exports (fob) Rs m8628815 
Imports (cif) Rs m8096281,4561,6742,465 
Fx inflow Rs m96291115 
Fx outflow Rs m1,2031,0511,9111,7822,677 
Net fx Rs m-1,194-1,044-1,882-1,772-2,662 
WYETH LTD CASH FLOW
From Operations Rs m 602 578 1,510 764 923 
From Investments Rs m 142 101 115 313 317 
From Financial Activity Rs m -801 -863 -936 -188 -481 
Net Cashflow Rs m -57 -184 689 889 759 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

WYETH LTD Raw Materials Data

ITEM Rs m % To R.M.C. % To SALES
Levonogestrel/nogestrel 37.0 4.5 0.5
Others 240.6 29.5 3.4
Prednisolone 538.4 66.0 7.7

Share Holding

Indian Promoters 0.0%
Foreign collaborators 51.1%
Indian inst/Mut Fund 11.3%
FIIs 7.2%
ADR/GDR 0.0%
Free float 30.4%
Shareholders 21,978
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Level 6, Platina, Plot No. C-59, G Block, BKC, Bandra (E), Mumbai - 400 098
E-MAIL thakorn@wyeth.com WEB www.wyethindia.com
TELEPHONE (022) 2657 4000 FAX (022) 2657 4100
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR B. S. R & Assoc.
CHM: Pradip Shah COMP SEC: Neema Thakore YEAR OF INC: 1947 BSE CODE: 500095 FV (Rs): 10 DIV YIELD (%): 1.3

More Pharmaceuticals Company Fact Sheets:   BIOCON LTD  ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  AMAR REMEDIES  

Compare WYETH LTD With:   BIOCON LTD  ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  AMAR REMEDIES  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Flat in Final Hour Sell Off; HDFC Twins Surge(Closing)

Indian share markets witnessed selling pressure in the final hour of trade but still closed at a record high for a third straight session.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The Real Returns from Real Estate Have Been Very Low(Vivek Kaul's Diary)

Jul 17, 2017

Real estate prices across India have barely gone anywhere over the last four years. Prices have fallen in many cities over the last one-year, new data from the National Housing Bank suggests.

Trade the Markets like Roger Federer Plays Tennis(Daily Profit Hunter)

Jul 19, 2017

Trading is one of the most competitive fields in the world today. To win, you must adopt the mindset of a Grand Slam champion.

Sold Your Immoveable Property? Here Are The Tax Implications...(Outside View)

Jul 19, 2017

When you're selling an immoveable property, it becomes imperative to recognise the intricate tax implications.

Why Keeping Unrealistic Expectations From Investments Is Stupid!(Outside View)

Jul 18, 2017

When investing, keeping realistic returns is necessary and it is not the only thing you should look at.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WYETH LTD

WYETH LTD - TEVA PHARMA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS